Time of infliximab therapy initiation and dose escalation in Crohn&rsquo;s disease

doi:10.3748/wjg.v20.i1.214

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5725)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

316

WORD

279

HTML

2816

Figures (1-1)

247

Tables (1-3)

247

Sum=3905

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

961

Download

859

Sum=1820

Jan 7, 2014 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 7, 2014; 20(1): 214-218
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.214

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curves to compare the time to dose escalation for the subgroups.

Citation: Lam MC, Lee T, Atkinson K, Bressler B. Time of infliximab therapy initiation and dose escalation in Crohn’s disease. World J Gastroenterol 2014; 20(1): 214-218
URL: https://www.wjgnet.com/1007-9327/full/v20/i1/214.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i1.214